| __timestamp | Incyte Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 214161000 |
| Thursday, January 1, 2015 | 753751000 | 283703000 |
| Friday, January 1, 2016 | 1105719000 | 346620000 |
| Sunday, January 1, 2017 | 1536216000 | 507666000 |
| Monday, January 1, 2018 | 1881883000 | 599674000 |
| Tuesday, January 1, 2019 | 2158759000 | 1123000000 |
| Wednesday, January 1, 2020 | 2666702000 | 729000000 |
| Friday, January 1, 2021 | 2986267000 | 810000000 |
| Saturday, January 1, 2022 | 3394635000 | 587000000 |
| Sunday, January 1, 2023 | 3695649000 | 787647000 |
| Monday, January 1, 2024 | 4241217000 | 705138000 |
Unlocking the unknown
In the competitive world of biotechnology, revenue growth is a key indicator of success. From 2014 to 2023, Incyte Corporation and Ionis Pharmaceuticals, Inc. have shown distinct trajectories. Incyte's revenue surged by over 620%, starting from approximately $511 million in 2014 to nearly $3.7 billion in 2023. This impressive growth reflects Incyte's strategic advancements and market penetration.
Conversely, Ionis Pharmaceuticals experienced a more modest growth of around 268% over the same period, with revenues increasing from about $214 million to $788 million. Despite the slower pace, Ionis has maintained a steady upward trend, showcasing its resilience and potential in the biotech sector.
This comparison highlights the dynamic nature of the biotech industry, where strategic innovation and market adaptability can lead to significant financial growth.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Breaking Down Revenue Trends: Incyte Corporation vs BioMarin Pharmaceutical Inc.
Incyte Corporation vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Incyte Corporation and Bausch Health Companies Inc. Performance Compared
Revenue Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Incyte Corporation or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Incyte Corporation and Geron Corporation: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Ascendis Pharma A/S vs Ionis Pharmaceuticals, Inc.
Annual Revenue Comparison: Pharming Group N.V. vs Ionis Pharmaceuticals, Inc.
Revenue Showdown: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Revenue Performance: Ionis Pharmaceuticals, Inc. or Perrigo Company plc?
Comparing Revenue Performance: Ionis Pharmaceuticals, Inc. or Merus N.V.?